[1]
“Patient in treatment of mammary neoplasia without her-2 hyperexperssion, evolving with cardiotoxicity, symptom left ventricular dysfunction”, Acervo Saúde, no. 20, p. e612, Mar. 2019, doi: 10.25248/reas.e612.2019.